Wanbury Ltd Performance
Day's Low
Day's High
₹237.05₹254.552 Week's Low
52 Week's High
₹85.45₹290.2
| Returns % | |
| 1 Month Return | -9.82 % |
| 3 Month Return | + 27.22 % |
| 1 Year Return | + 175.39 % |
| Market Stats | |
| Previous Close | ₹249.50 |
| Open | ₹251.95 |
| Volume | 36.05K |
| Upper Circuit | - |
| Lower Circuit | - |
| Market Cap | ₹817.37Cr |
Wanbury Ltd Key Statistics
| P/E Ratio | 15.6 |
| PEG Ratio | 1.01 |
| Market Cap | ₹817.37 Cr |
| P/B Ratio | 21.77 |
| EPS | 17.09 |
| Dividend Yield | 0 |
| Sector | Pharmaceuticals |
| ROE | 38.26 |
Wanbury Ltd Peer Comparison
Company | Analyst View | Market Cap | 5 Year CAGR | Debt to Asset Ratio | Net Profit | Yearly Revenue |
|---|---|---|---|---|---|---|
| NA | ₹817.37 Cr | 417.72% | 0.91 | ₹55 Cr | ₹575 Cr | |
| NA | ₹207.23 Cr | 49.33% | 0.79 | ₹7 Cr | ₹339 Cr | |
| NA | ₹10.56 Cr | 219.49% | 0.50 | NA | NA | |
| BUY | ₹6,511.04 Cr | 14.02% | 0.62 | ₹48 Cr | ₹717 Cr | |
| NA | ₹28.64 Cr | 67.38% | 0.50 | NA | NA |
About Wanbury Ltd
Share Price: ₹243.30 per share as on 21 Oct, 2024 04:01 PM
Market Capitalisation: ₹817.37Cr as of today
Revenue: ₹131.11Cr as on June 2024 (Q2 24)
Net Profit: ₹1.04Cr as on June 2024 (Q2 24)
Listing date: 29 Jan, 2007
Chairperson Name: K Chandran
| Organisation | Wanbury Ltd |
| Headquarters | |
| Industry | Pharmaceuticals |
| E-voting on shares | Click here to vote |
Key events for Wanbury Ltd
Wanbury Shares Surge on New API Launch Announcements - 12 Sep, 2024
Wanbury Ltd's shares hit a 5% upper circuit after announcing the launch of two new APIs, Dextromethorphan and Ketamine, alongside a robust pipeline of products. Despite a decline in quarterly profits, the stock has appreciated significantly year-to-date.
Wanbury Secures CEP for Cough Relief Drug - 09 Sep, 2024
Wanbury Ltd. has received a Certificate of Suitability for its cough suppressant Dextromethorphan, allowing sales in Europe. The company faces challenges with declining profits and revenues due to facility upgrades.
Wanbury Shares Rise After USFDA Inspection Success - 23 Aug, 2024
Wanbury Ltd's shares surged after receiving an Establishment Inspection Report from the USFDA with zero observations, indicating compliance with good manufacturing practices. The company also received awards for safety performance.
Wanbury Reports Decline in Sales and Profit - 17 Aug, 2024
Wanbury's June 2024 net sales fell 10.38% to Rs 131.11 crore, with net profit down 77.87% to Rs 1.04 crore. Despite this, shares have gained 11.87% over six months and 237.21% over the past year.
Insights on Wanbury Ltd
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTBest in 3 Years
In the last 3 years, WANBURY has outperformed top 5 stocks with highest market-cap in Pharmaceuticals
- POSITIVE IMPACT
Best in 1 Year
In the last 1 year, WANBURY has outperformed top 5 stocks with highest market-cap in Pharmaceuticals
- POSITIVE IMPACT
Price Rise
In the last 1 year, WANBURY stock has moved up by 175.4%
- POSITIVE IMPACT
FII Holding Up
Foreign Institutions have increased holdings from 0.22% to 1.02% in Sep 2024 quarter
NEGATIVE IMPACTProfit Down
Netprofit is down for the last 2 quarters, 33.63 Cr → 1.04 Cr (in ₹), with an average decrease of 96.9% per quarter
- NEGATIVE IMPACT
Retail Holding Down
Retail Investor have decreased holdings from 59.98% to 59.20% in Sep 2024 quarter
- NEGATIVE IMPACT
Promoter Holding Down
Promoters have decreased holdings from 39.79% to 39.77% in Sep 2024 quarter
- NEGATIVE IMPACT
Revenue Fall
Revenue is down for the last 2 quarters, 165.89 Cr → 132.05 Cr (in ₹), with an average decrease of 20.4% per quarter
Wanbury Ltd Financials
Wanbury Ltd Shareholding Pattern
| Investors | Holdings % | FY Quarter | 3M change |
|---|---|---|---|
| Promoter Holdings | 39.77% | ||
| Foreign Institutions | 1.02% | 356.34 | |
| Mutual Funds | 0% | 0.00 | |
| Retail Investors | 59.2% | ||
| Others | 0% | 6.25 |
Wanbury Ltd Key Indicators
Wanbury Ltd Valuation
Wanbury Ltd in the last 5 years
Lowest (-105.12x)
July 15, 2021
Today (15.60x)
October 18, 2024
Industry (58.10x)
October 18, 2024
Highest (146.91x)
September 29, 2023
Wanbury Ltd Earnings and Dividends
Wanbury Ltd Earnings Results
Wanbury Ltd’s net profit fell -77.83% since last year same period to ₹1.04Cr in the Q1 2024-2025. On a quarterly growth basis, Wanbury Ltd has generated -96.91% fall in its net profits since last 3-months.
Read More about Earnings Results
Wanbury Ltd Technicals Summary
Bearish
Neutral
Bullish
Wanbury Ltd is currently in a Bullish trading position according to technical analysis indicators.
FAQs on Wanbury Ltd
- Get a PAN card.
- Open a Demat account.
- Open a Trading account.
- Link your Demat account to your Trading account.
- Fund your Trading account.
- Place an order to buy Wanbury Ltd shares.
Wanbury Ltd (WANBURY) share price today is ₹243.3
Wanbury Ltd is listed on NSE
Wanbury Ltd is listed on BSE
- Today’s highest price of Wanbury Ltd is ₹254.5.
- Today’s lowest price of Wanbury Ltd is ₹237.05.
PE Ratio of Wanbury Ltd is 15.6
PE ratio = Wanbury Ltd Market price per share / Wanbury Ltd Earnings per share
Today’s traded volume of Wanbury Ltd(WANBURY) is 36.05K.
Today’s market capitalisation of Wanbury Ltd(WANBURY) is ₹817.37Cr.
| Wanbury Ltd(WANBURY | Price |
|---|---|
52 Week High | ₹290.2 |
52 Week Low | ₹85.45 |
Wanbury Ltd(WANBURY) share price is ₹243.3. It is down -16.16% from its 52 Week High price of ₹290.2
Wanbury Ltd(WANBURY) share price is ₹243.3. It is up 184.73% from its 52 Week Low price of ₹85.45
| Wanbury Ltd(WANBURY | Returns |
|---|---|
1 Day Returns | -6.2% |
1 Month Returns | -9.82% |
3 Month Returns | 27.22% |
1 Year Returns | 175.39% |